In his State of the Union address last night, President Obama said he wants to “make America the country that cures cancer once and for all.”

A key piece of that “moonshot” – as the president and vice president have called it – may be a treatment that’s still very much in the experimental phase: personalized cancer vaccines.

Here & Now’s Jeremy Hobson talks with STAT senior science writer Sharon Begley about how those personalized vaccines – called neoantigen vaccines – work, and why they could become a central player in the push to cure cancer.

Guest

Copyright 2016 NPR. To see more, visit NPR.

300x250 Ad

Support quality journalism, like the story above, with your gift right now.

Donate